Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Lung Cancer (Amsterdam, Netherlands)|July 27, 2023
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutationsAndreas N Saltos, Ben C Creelan, Tawee Tanvetyanon, et al.Cell Reports|March 25, 2015
FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cellsDewen You, Junping Xin, Andrew Volk, et al.Journal of Oncology Practice|May 21, 2015
Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer CareTawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, et al.Therapeutic Advances in Medical Oncology|November 25, 2024
Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung CancerJhanelle E Gray, Andreas Saltos, Tawee Tanvetyanon, et al.Journal of Oncology Practice|April 17, 2014
Changes in the care of non-small-cell lung cancer after audit and feedback: the Florida initiative for quality cancer careTawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.The Journal of Experimental Medicine|May 21, 2014
Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AMLAndrew Volk, Jing Li, Junping Xin, et al.Oncotargets and Therapy|September 19, 2017
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumorsBen C Creelan, Dmitry I Gabrilovich, Jhanelle E Gray, et al.Journal of Oncology Practice|October 30, 2014
Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year IntervalPaul B Jacobsen, Ji-Hyun Lee, William Fulp, et al.Pageof 14